2 studies on Aromatase inhibition mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
**Clinicians and peptide users co-administering testosterone with GHRP-2 should recognize that testosterone itself — not its aromatized or 5alpha-reduced metabolites — is the primary amplifier of GHRP-2-driven pulsati…
**Clinicians and users employing GHRP-2 in hormonal contexts must account for background androgen status**: higher DHT strongly attenuates stimulated cortisol pulsatility, meaning men on 5α-reductase inhibitors (e.g.,…